Evidence map›Paper›PMID 35187531›Full record

ReviewFrontiers in genome editing2022

Mini-Review: Transgenerational CRISPR/Cas9 Gene Editing in Plants.

Lennert Impens, Thomas B Jacobs, Hilde Nelissen, Dirk Inzé, Laurens Pauwels

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in genome editing, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Advances in Genome Editing Through Haploid Induction Systems.International journal of molecular sciences · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. The Transcription FactorsInternational journal of molecular sciences · 2023
    Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Virus-Induced Gene Editing and Its Applications in Plants.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Lennert ImpensDepartment of Plant Biotechnology and Bioinformatics, Ghent University, Ghent, Belgium.
Thomas B JacobsDepartment of Plant Biotechnology and Bioinformatics, Ghent University, Ghent, Belgium.
Hilde NelissenDepartment of Plant Biotechnology and Bioinformatics, Ghent University, Ghent, Belgium.
Dirk InzéDepartment of Plant Biotechnology and Bioinformatics, Ghent University, Ghent, Belgium.
Laurens PauwelsDepartment of Plant Biotechnology and Bioinformatics, Ghent University, Ghent, Belgium.
Ghent University · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CRISPR/Cas9 genome editing has been used extensively in a wide variety of plant species. Creation of loss-of-function alleles, promoter variants and mutant collections are a few of the many uses of genome editing. In a typical workflow for sexually reproducing species, plants are generated that contain an integrated CRISPR/Cas9 transgene. After editing of the gene of interest, T-DNA null segregants can be identified in the next generation that contain only the desired edit. However, maintained presence of the CRISPR/Cas9 transgene and continued editing in the subsequent generations offer a range of applications for model plants and crops. In this review, we define transgenerational gene editing (TGE) as the continued editing of CRISPR/Cas9 after a genetic cross. We discuss the concept of TGE, summarize the current main applications, and highlight special cases to illustrate the importance of TGE for plant genome editing research and breeding.

Indexed as

CRISPR/Cas9egg cellfloral dipgene editingHI-Editpollen

Identifiers

PMID35187531
PMCPMC8854858
OpenAlexW4210415550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.